• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

物质使用障碍对精神分裂症的表现及短期病程的影响。

Impact of substance use disorder on presentation and short-term course of schizophrenia.

作者信息

Chakraborty Rudraprosad, Chatterjee Arunima, Chaudhury Suprakash

机构信息

Berhampore Mental Hospital, Murshidabad, West Bengal, Berhampore 742101, India.

Pravara Institute of Medical Sciences (Deemed University), Rural Medical College, District of Ahmednagar, Loni, Maharashtra 413736, India.

出版信息

Psychiatry J. 2014;2014:280243. doi: 10.1155/2014/280243. Epub 2014 Apr 2.

DOI:10.1155/2014/280243
PMID:24839596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3997163/
Abstract

The aim of the present study was to compare a cohort of schizophrenia patients with substance use disorder (SUD) with a similar cohort of schizophrenia patients without SUD with regard to sociodemographic variables, clinical variables, psychopathology, anxiety symptoms, depressive symptoms, treatment outcome, and side effect profile of drugs. A total of 143 consecutive inpatients with ICD-10 DCR diagnosis of schizophrenia were included after obtaining informed consent. Patients were evaluated by a semistructured data sheet and Maudsley Addiction Profile. They were then rated by Positive and Negative Symptoms Scale, Calgary Depression Scale, Hamilton Anxiety Rating Scale, and Brief Psychiatric Rating Scale at presentation, three weeks, and six weeks. At three weeks and six weeks, they were also evaluated by UKU Side Effect Rating Scale. Substance abuse was detected in 63.6% schizophrenia patients. Nicotine was the commonest substance followed by cannabis and alcohol. Substance users had longer untreated illness and more depressive symptoms at presentation and six-week follow-up. Dual diagnosis patients had difficulty in abstraction at three and six weeks but not at presentation. Schizophrenia patients with SUD had more depressive symptoms. SUD appeared to mask abstraction difficulties at presentation. Schizophrenia patients with SUD should be carefully assessed for presence of depression.

摘要

本研究的目的是比较一组患有物质使用障碍(SUD)的精神分裂症患者与一组无SUD的类似精神分裂症患者在社会人口统计学变量、临床变量、精神病理学、焦虑症状、抑郁症状、治疗结果及药物副作用方面的情况。在获得知情同意后,纳入了143例连续的符合ICD - 10 DCR诊断标准的精神分裂症住院患者。患者通过一份半结构化数据表和莫兹利成瘾量表进行评估。随后,在入院时、三周及六周时分别采用阳性和阴性症状量表、卡尔加里抑郁量表、汉密尔顿焦虑评定量表及简明精神病评定量表进行评分。在三周及六周时,还采用UKU副作用评定量表对患者进行评估。63.6%的精神分裂症患者被检测出存在物质滥用情况。尼古丁是最常见的物质,其次是大麻和酒精。物质使用者在入院时及六周随访时的未治疗病程更长,抑郁症状更多。双重诊断患者在三周及六周时存在抽象思维困难,但入院时不存在。患有SUD的精神分裂症患者抑郁症状更多。SUD似乎在入院时掩盖了抽象思维困难。对于患有SUD的精神分裂症患者,应仔细评估其是否存在抑郁。

相似文献

1
Impact of substance use disorder on presentation and short-term course of schizophrenia.物质使用障碍对精神分裂症的表现及短期病程的影响。
Psychiatry J. 2014;2014:280243. doi: 10.1155/2014/280243. Epub 2014 Apr 2.
2
Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with Quetiapine.精神分裂症和物质使用障碍患者物质使用、神经和精神症状的演变:一项使用喹硫平的为期12周的先导性病例对照试验。
Front Psychiatry. 2011 May 13;2:22. doi: 10.3389/fpsyt.2011.00022. eCollection 2011.
3
Prevalence of Substance Use in Patients Diagnosed with Schizophrenia.被诊断为精神分裂症患者的物质使用患病率。
Noro Psikiyatr Ars. 2016 Mar;53(1):4-11. doi: 10.5152/npa.2015.8827. Epub 2016 Mar 1.
4
A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: changes in psychiatric symptoms and substance use.一项针对精神分裂症谱系障碍和药物滥用患者的为期12个月的前瞻性随访研究:精神症状和药物使用的变化。
Schizophr Res. 2006 Mar;83(1):65-75. doi: 10.1016/j.schres.2005.11.019. Epub 2006 Feb 7.
5
The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.物质使用障碍对门诊精神科诊所中焦虑和抑郁临床表现的影响。
J Clin Psychiatry. 1995 Dec;56(12):549-55.
6
[Cannabis and schizophrenia: demographic and clinical correlates].[大麻与精神分裂症:人口统计学及临床相关性]
Encephale. 2003 Jan-Feb;29(1):11-7.
7
Does substance use disorder affect clinical expression in first-hospitalization patients with schizophrenia? Analysis of a prospective cohort.物质使用障碍是否会影响首次住院精神分裂症患者的临床表现?一项前瞻性队列研究分析。
Psychiatry Res. 2013 Dec 30;210(3):780-6. doi: 10.1016/j.psychres.2013.08.043. Epub 2013 Sep 18.
8
Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia.近期发病精神分裂症中的共病物质滥用与神经认知功能
Eur Arch Psychiatry Clin Neurosci. 2007 Jun;257(4):203-10. doi: 10.1007/s00406-006-0707-x. Epub 2006 Nov 25.
9
Clozapine use in patients with schizophrenia and a comorbid substance use disorder: A systematic review.精神分裂症合并物质使用障碍患者中氯氮平的应用:一项系统评价。
Eur Neuropsychopharmacol. 2018 Feb;28(2):227-242. doi: 10.1016/j.euroneuro.2017.12.006. Epub 2017 Dec 19.
10
Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.可溶性白细胞介素-2 受体水平与精神分裂症谱系障碍中喹硫平治疗期间的阳性症状相关。
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1695-8. doi: 10.1016/j.pnpbp.2011.05.011. Epub 2011 May 24.

引用本文的文献

1
THE THEORY OF MIND AND PSYCHOTIC SYMPTOMS PHENOMENOLOGY IN SUBSTANCE-INDUCED PSYCHOTIC DISORDER AND SCHIZOPHRENIA.物质所致精神障碍和精神分裂症中的心理理论与精神病性症状现象学
Turk Psikiyatri Derg. 2024 Sep 19;35(4):253-62. doi: 10.5080/u27310.
2
Receptor-Mediated AKT/PI3K Signalling and Behavioural Alterations in Zebrafish Larvae Reveal Association between Schizophrenia and Opioid Use Disorder.受体介导的 AKT/PI3K 信号转导与斑马鱼幼鱼行为改变揭示精神分裂症与阿片类药物使用障碍的关联。
Int J Mol Sci. 2022 Apr 25;23(9):4715. doi: 10.3390/ijms23094715.
3
Sociodemographic and clinical profile of cannabis-induced psychosis: A comparative study.大麻所致精神病的社会人口学和临床特征:一项对比研究。
Ind Psychiatry J. 2021 Oct;30(Suppl 1):S132-S139. doi: 10.4103/0972-6748.328804. Epub 2021 Oct 22.
4
Alcohol Use Disorder and Its Associate Factors Relating to Patients with Severe Mental Disorders Attending Psychiatric Follow-Ups in Northwest Ethiopia.埃塞俄比亚西北部接受精神科随访的重度精神障碍患者的酒精使用障碍及其相关因素
Neuropsychiatr Dis Treat. 2021 Jun 4;17:1801-1810. doi: 10.2147/NDT.S309704. eCollection 2021.
5
An overview of Indian research in schizophrenia.印度精神分裂症研究概述。
Indian J Psychiatry. 2010 Jan;52(Suppl 1):S159-72. doi: 10.4103/0019-5545.69229.

本文引用的文献

1
DSM-5 criteria for substance use disorders: recommendations and rationale.DSM-5 物质使用障碍标准:建议和原理。
Am J Psychiatry. 2013 Aug;170(8):834-51. doi: 10.1176/appi.ajp.2013.12060782.
2
The lifetime and past-year prevalence of dual diagnosis in people with schizophrenia across Europe: findings from the European Schizophrenia Cohort (EuroSC).欧洲精神分裂症队列研究(EuroSC)发现:欧洲精神分裂症患者双相诊断的终身和过去一年的流行率。
Eur Arch Psychiatry Clin Neurosci. 2012 Oct;262(7):607-16. doi: 10.1007/s00406-012-0305-z. Epub 2012 Mar 17.
3
Demographic and clinical correlates of substance abuse comorbidity in schizophrenia.精神分裂症患者药物滥用共病的人口统计学和临床相关性。
Indian J Psychiatry. 2004 Apr;46(2):135-9.
4
Cannabis use and earlier onset of psychosis: a systematic meta-analysis.大麻使用与精神病的早发:一项系统的荟萃分析。
Arch Gen Psychiatry. 2011 Jun;68(6):555-61. doi: 10.1001/archgenpsychiatry.2011.5. Epub 2011 Feb 7.
5
Substance use disorders in schizophrenia--clinical implications of comorbidity.精神分裂症中的物质使用障碍——共病的临床意义。
Schizophr Bull. 2009 May;35(3):469-72. doi: 10.1093/schbul/sbp016. Epub 2009 Mar 26.
6
Variations in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK. A systematic review.英国心理健康机构与地理区域之间精神病共病物质使用发生率的差异。一项系统综述。
Soc Psychiatry Psychiatr Epidemiol. 2009 Jun;44(6):429-47. doi: 10.1007/s00127-008-0458-2. Epub 2008 Nov 13.
7
Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study.精神分裂症共病物质使用的自然主义随访:西伦敦首发研究
Psychol Med. 2008 Jan;38(1):79-88. doi: 10.1017/S0033291707000797. Epub 2007 May 29.
8
Schizophrenia and co-occurring substance use disorder.精神分裂症与共病物质使用障碍
Am J Psychiatry. 2007 Mar;164(3):402-8. doi: 10.1176/ajp.2007.164.3.402.
9
Substance misuse and cognitive functioning in early psychosis: a 2 year follow-up.早期精神病中的物质滥用与认知功能:一项为期2年的随访研究。
Schizophr Res. 2006 Dec;88(1-3):187-91. doi: 10.1016/j.schres.2006.06.040. Epub 2006 Aug 30.
10
Differing correlates for suicide attempts among patients with schizophrenia or schizoaffective disorder in India and USA.印度和美国精神分裂症或分裂情感性障碍患者自杀未遂的不同相关因素。
Schizophr Res. 2006 Sep;86(1-3):208-14. doi: 10.1016/j.schres.2006.04.015. Epub 2006 Jun 15.